(PharmaNewsWire.Com, July 11, 2017 ) The Latin America Preclinical in-vivo imaging market has been estimated at USD 89.40 Million in 2016 and is projected to reach USD 124.98 Million by 2021, at a CAGR of 6.93% during the forecast period from 2016 to 2021. Preclinical imaging systems are imaging systems that look deep into the tissues of living subjects. In-vivo imaging requires a simultaneous combination of imaging modalities to examine dynamic characteristics of cells and tissues.
In Latin America, increased outsourcing of preclinical research activities to Latin America based CROs by big pharmaceutical and biotechnological companies, owing to low cost of research in these nations is driving the market growth. However, high cost and data requirements for bringing new imaging technology is the key reason hampering the growth of preclinical imaging market in this region.
Latin America market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the Latin America preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the Latin America preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.
Geographically, Latin America market for Preclinical In-vivo Imaging is segmented into Brazil, Argentina and Mexico. Rising adoption of multi-modality imaging systems in preclinical research studies and growing number of CROs in emerging markets like Brazil, are attracting the companies to invest in Latin American region.
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the Latin America preclinical imaging systems market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
